Gerard Honig

Gerard-Honig

Crohn’s & Colitis Foundation

Gerard Honig is dedicated to accelerating the development of innovative products with the potential to benefit patients. At the Crohn’s & Colitis Foundation, a patient advocacy organization and leading funder of research in inflammatory bowel diseases, he manages a recently launched venture philanthropy fund. Gerard received his PhD in neuroscience at the University of California San Francisco as a fellow of the Howard Hughes Medical Institute and subsequently trained in immunology and microbiome research. In 2013, Gerard developed a novel clinical-stage therapeutic modality for the treatment of Clostridium difficile infection. This experience led him to found Symbiotic Health Inc., a biotechnology company focused on the development of novel drug delivery systems. Gerard serves on numerous boards and committees, including the board of directors of the Peggy Lillis Foundation; the review committee for the Robertson Therapeutic Development Fund at Rockefeller University; and the alumni committee for Entrepreneurship Lab NYC. In his spare time, Gerard enjoys Japanese martial arts and cooking.

 

Gerard Honig is an alum of ElabNYC.

Newsletter Signup

Corporate Supporters

Pfizer Logo

ELabNYC is a Program of

Initiated by